相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Bcr-TMP, a Novel Nanomolar-Active Compound That Exhibits Both MYB- and Microtubule-Inhibitory Activity
Maria V. Yusenko et al.
CANCERS (2022)
Report Single-cell RNA sequencing identifies a paracrine interaction that may drive oncogenic notch signaling in human adenoid cystic carcinoma
Anuraag S. Parikh et al.
CELL REPORTS (2022)
Current opinions on diagnosis and treatment of adenoid cystic carcinoma
Yan Fang et al.
ORAL ONCOLOGY (2022)
Rearrangements, Expression, and Clinical Significance of MYB and MYBL1 in Adenoid Cystic Carcinoma: A Multi-Institutional Study
Marta Persson et al.
CANCERS (2022)
Clinical disease course and survival outcomes following disease recurrence in adenoid cystic carcinoma with and without NOTCH signaling pathway activation
Laura Feeney et al.
ORAL ONCOLOGY (2022)
A Randomized Phase 2 Study of Pembrolizumab With or Without Radiation in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma
Umair Mahmood et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)
Analysis of the clinicopathological characteristics and prognosis of adenoid cystic carcinoma of the intraoral minor salivary glands: a retrospective study of 40 cases
J-f He et al.
INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2021)
Proteasome inhibitors suppress MYB oncogenic activity in a p300-dependent manner
Maria V. Yusenko et al.
CANCER LETTERS (2021)
Recent advances of dual FGFR inhibitors as a novel therapy for cancer
Qi Liang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Adenoid cystic carcinoma: a review of clinical features, treatment targets and advances in improving the immune response to monoclonal antibody therapy
James Nightingale et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2021)
The utility of TP53 and PIK3CA mutations as prognostic biomarkers in salivary adenoid cystic carcinoma
Helen Adderley et al.
ORAL ONCOLOGY (2021)
MYB oncoproteins: emerging players and potential therapeutic targets in human cancer
Ylenia Ciciro et al.
ONCOGENESIS (2021)
Prognosis and management of recurrent and/or metastatic head and neck adenoid cystic carcinoma
Luigi Lorini et al.
ORAL ONCOLOGY (2021)
Detection of novel fusion genes by next-generation sequencing-based targeted RNA sequencing analysis in adenoid cystic carcinoma of head and neck
Eri Shibata et al.
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY (2021)
A phase II trial of all-trans retinoic acid (ATRA) in advanced adenoid cystic carcinoma
Glenn J. Hanna et al.
ORAL ONCOLOGY (2021)
Proteomics, Personalized Medicine and Cancer
Miao Su et al.
CANCERS (2021)
Apatinib in patients with recurrent or metastatic adenoid cystic carcinoma of the head and neck: a single-arm, phase II prospective study
Guopei Zhu et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2021)
MYB RNA In Situ Hybridization Facilitates Sensitive and Specific Diagnosis of Adenoid Cystic Carcinoma Regardless of Translocation Status
Lisa M. Rooper et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2021)
Proteogenomic Analysis of Salivary Adenoid Cystic Carcinomas Defines Molecular Subtypes and Identifies Therapeutic Targets
Renata Ferrarotto et al.
CLINICAL CANCER RESEARCH (2021)
The Utility of MYB Immunohistochemistry (IHC) in Fine Needle Aspiration (FNA) Diagnosis of Adenoid Cystic Carcinoma (AdCC)
Tong Sun et al.
HEAD & NECK PATHOLOGY (2021)
Safety and clinical activity of the Notch inhibitor, crenigacestat (LY3039478), in an open-label phase I trial expansion cohort of advanced or metastatic adenoid cystic carcinoma
C. Even et al.
INVESTIGATIONAL NEW DRUGS (2020)
Patients with adenoid cystic carcinomas of the salivary glands treated with lenvatinib: Activity and quality of life
Laura D. Locati et al.
CANCER (2020)
Monensin, a novel potent MYB inhibitor, suppresses proliferation of acute myeloid leukemia and adenoid cystic carcinoma cells
Maria Yusenko et al.
CANCER LETTERS (2020)
A Phase II Trial of Pembrolizumab and Vorinostat in Recurrent Metastatic Head and Neck Squamous Cell Carcinomas and Salivary Gland Cancer
Cristina P. Rodriguez et al.
CLINICAL CANCER RESEARCH (2020)
Risk factors for survival and distant metastasis in 125 patients with head and neck adenoid cystic carcinoma undergoing primary surgery
In Seong Jeong et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2020)
ATR is a MYB regulated gene and potential therapeutic target in adenoid cystic carcinoma
Mattias K. Andersson et al.
ONCOGENESIS (2020)
Shallow whole genome sequencing of adenoid cystic carcinomas of the salivary glands identifies specific chromosomal aberrations related to tumor progression
R. Cordesmeyer et al.
ORAL ONCOLOGY (2020)
Long-term outcomes and clinicogenomic correlates in recurrent, metastatic adenoid cystic carcinoma
Glenn J. Hanna et al.
ORAL ONCOLOGY (2020)
Adenoid cystic carcinoma cytology: Salivary gland and nonsalivary gland
Sayanan Chowsilpa et al.
DIAGNOSTIC CYTOPATHOLOGY (2020)
Mammalian SWI/SNF Chromatin Remodeling Complexes: Emerging Mechanisms and Therapeutic Strategies
Richard C. Centore et al.
TRENDS IN GENETICS (2020)
KIT/PDGFRA/KDR amplification defines a novel molecular subtype of adenoid cystic carcinoma patients who may benefit from treatment with tyrosine kinase inhibitors
Helei Hou et al.
TRANSLATIONAL CANCER RESEARCH (2020)
Tyrosine kinase inhibitors for solid tumors in the past 20 years (2001-2020)
Liling Huang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
The NOTCH1-HEY1 pathway regulates self-renewal and epithelial-mesenchymal transition of salivary adenoid cystic carcinoma cells
Jing Xie et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2020)
t(6;9)(MYB-NFIB) in head and neck adenoid cystic carcinoma: A systematic review with meta-analysis
Yasmin Dias de Almeida-Pinto et al.
ORAL DISEASES (2019)
SWI/SNF chromatin remodeling controls Notch-responsive enhancer accessibility
Zoe Pillidge et al.
EMBO REPORTS (2019)
Phase II Study of Lenvatinib in Patients With Progressive, Recurrent or Metastatic Adenoid Cystic Carcinoma
Vatche Tchekmedyian et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Phase II trial with axitinib in recurrent and/or metastatic salivary gland cancers of the upper aerodigestive tract
Laura D. Locati et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2019)
Role of c-Kit in Myocardial Regeneration and Aging
Fabiola Marino et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Genetic hallmarks of recurrent/metastatic adenoid cystic carcinoma
Allen S. Ho et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
The success and the challenge of all-trans retinoic acid in the treatment of cancer
Xiaoling Ni et al.
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2019)
Advanced adenoid cystic carcinoma (ACC) is featured by SWI/SNF chromatin remodeling complex aberrations
Beata Jagielska et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2019)
Analysis of clinicopathological characteristics, MYB rearrangement and prognostic factors in salivary adenoid cystic carcinoma
Jing Han et al.
ONCOLOGY LETTERS (2019)
A phase I dose-escalation and dose-expansion study of brontictuzumab in subjects with selected solid tumors
R. Ferrarotto et al.
ANNALS OF ONCOLOGY (2018)
Molecular features of adenoid cystic carcinoma with an emphasis on microRNA expression
Simon Andreasen
APMIS (2018)
A multi-arm phase I dose escalating study of an oral NOTCH inhibitor BMS-986115 in patients with advanced solid tumours
Kyaw L. Aung et al.
INVESTIGATIONAL NEW DRUGS (2018)
MYB and MYBL1 in adenoid cystic carcinoma: diversity in the mode of genomic rearrangement and transcripts
Yuki Togashi et al.
MODERN PATHOLOGY (2018)
Mutation analysis of the EGFR pathway genes, EGFR, RAS, PIK3CA, BRAF, and AKT1, in salivary gland adenoid cystic carcinoma
Kosuke Saida et al.
Oncotarget (2018)
UM-HACC-2A: MYB-NFIB fusion-positive human adenoid cystic carcinoma cell line
Kristy A. Warner et al.
ORAL ONCOLOGY (2018)
Opposing roles of KIT and ABL1 in the therapeutic response of gastrointestinal stromal tumor (GIST) cells to imatinib mesylate
Jessica L. Rausch et al.
ONCOTARGET (2017)
MYB, MYBL1, MYBL2 and NFIB gene alterations and MYC overexpression in salivary gland adenoid cystic carcinoma
Kana Fujii et al.
HISTOPATHOLOGY (2017)
Activating NOTCH1 Mutations Define a Distinct Subgroup of Patients With Adenoid Cystic Carcinoma Who Have Poor Prognosis, Propensity to Bone and Liver Metastasis, and Potential Responsiveness to Notch1 Inhibitors
Renata Ferrarotto et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Clinical prognostic factors of salivary adenoid cystic carcinoma: A single-center analysis of 61 patients
Robert Cordesmeyer et al.
JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY (2017)
Targeting the Oncogenic Transcriptional Regulator MYB in Adenoid Cystic Carcinoma by Inhibition of IGF1R/AKT Signaling
Mattias K. Andersson et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Transcriptomes define distinct subgroups of salivary gland adenoid cystic carcinoma with different driver mutations and outcomes
Candace A. Frerich et al.
Oncotarget (2017)
Targeting the Oncogenic Transcriptional Regulator MYB in Adenoid Cystic Carcinoma by Inhibition of IGF1R/AKT Signaling
Mattias K. Andersson et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Nuclear Factor I/B: A Master Regulator of Cell Differentiation with Paradoxical Roles in Cancer
Daiana D. Becker-Santos et al.
EBIOMEDICINE (2017)
Diffuse Staining for Activated NOTCH1 Correlates With NOTCH1 Mutation Status and Is Associated With Worse Outcome in Adenoid Cystic Carcinoma
Dipti P. Sajed et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2017)
A Phase II Study of Dovitinib in Patients with Recurrent or Metastatic Adenoid Cystic Carcinoma
Patrick M. Dillon et al.
CLINICAL CANCER RESEARCH (2017)
Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors
S. J. Wong et al.
ANNALS OF ONCOLOGY (2016)
Novel MYBL1 Gene Rearrangements with Recurrent MYBL1-NFIB Fusions in Salivary Adenoid Cystic Carcinomas Lacking t(6;9) Translocations
Yoshitsugu Mitani et al.
CLINICAL CANCER RESEARCH (2016)
Differences in MYB expression and gene abnormalities further confirm that salivary cribriform basal cell tumors and adenoid cystic carcinoma are two distinct tumor entities
Zhen Tian et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2016)
Recurrent Fusions in MYB and MYBL1 Define a Common, Transcription Factor-Driven Oncogenic Pathway in Salivary Gland Adenoid Cystic Carcinoma
Kathryn J. Brayer et al.
CANCER DISCOVERY (2016)
A phase II study of axitinib (AG-013736) in patients with incurable adenoid cystic carcinoma
A. L. Ho et al.
ANNALS OF ONCOLOGY (2016)
Whole-Genome Sequencing of Salivary Gland Adenoid Cystic Carcinoma
Eleni M. Rettig et al.
CANCER PREVENTION RESEARCH (2016)
A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impact
L. D. Locati et al.
EUROPEAN JOURNAL OF CANCER (2016)
An oncogenic MYB feedback loop drives alternate cell fates in adenoid cystic carcinoma
Yotam Drier et al.
NATURE GENETICS (2016)
Clinical utility of myb rearrangement detection and p63/p40 immunophenotyping in the diagnosis of adenoid cystic carcinoma of minor salivary glands: a pilot study
Prokopios P. Argyris et al.
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY (2016)
Phase II study of gefitinib in patients with advanced salivary gland cancers
John A. Jakob et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2015)
Notch-1 knockdown suppresses proliferation, migration and metastasis of salivary adenoid cystic carcinoma cells
Wei Chen et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
MYB rearrangement and clinicopathologic characteristics in head and neck adenoid cystic carcinoma
Eleni M. Rettig et al.
LARYNGOSCOPE (2015)
Adenoid cystic carcinoma of the head and neck - An update
Andres Coca-Pelaz et al.
ORAL ONCOLOGY (2015)
Phase II trial of sorafenib in advanced salivary adenoid cystic carcinoma of the head and neck
David J. Thomson et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2015)
Efficacy of nelfinavir as monotherapy in refractory adenoid cystic carcinoma: Results of a phase II clinical trial
Andrew C. Hoover et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2015)
Comprehensive Genomic Profiling of Relapsed and Metastatic Adenoid Cystic Carcinomas by Next-generation Sequencing Reveals Potential New Routes to Targeted Therapies
Jeffrey S. Ross et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2014)
A multicenter phase II study of everolimus in patients with progressive unresectable adenoid cystic carcinoma
Dong-Wan Kim et al.
BMC CANCER (2014)
MYB immunostaining is a useful ancillary test for distinguishing adenoid cystic carcinoma from pleomorphic adenoma in fine-needle aspiration biopsy specimens
Marc P. Pusztaszeri et al.
CANCER CYTOPATHOLOGY (2014)
Analysis of MYB oncogene in transformed adenoid cystic carcinomas reveals distinct pathways of tumor progression
Ana F. Costa et al.
LABORATORY INVESTIGATION (2014)
Development and characterization of salivary adenoid cystic carcinoma cell line
Jie Li et al.
ORAL ONCOLOGY (2014)
c-Kit Expression is Rate-Limiting for Stem Cell Factor-Mediated Disease Progression in Adenoid Cystic Carcinoma of the Salivary Glands
Janyaporn Phuchareon et al.
Translational Oncology (2014)
NOTCH1 signaling contributes to cell growth, anti-apoptosis and metastasis in salivary adenoid cystic carcinoma
Bo-Hua Su et al.
ONCOTARGET (2014)
Whole exome sequencing of adenoid cystic carcinoma
Philip J. Stephens et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
The mutational landscape of adenoid cystic carcinoma
Allen S. Ho et al.
NATURE GENETICS (2013)
A phase II study of sunitinib in recurrent and/or metastatic adenoid cystic carcinoma (ACC) of the salivary glands: current progress and challenges in evaluating molecularly targeted agents in ACC
N. G. Chau et al.
ANNALS OF ONCOLOGY (2012)
Clinically significant copy number alterations and complex rearrangements of MYB and NFIB in head and neck adenoid cystic carcinoma
Marta Persson et al.
GENES CHROMOSOMES & CANCER (2012)
MYB Expression and Translocation in Adenoid Cystic Carcinomas and Other Salivary Gland Tumors With Clinicopathologic Correlation
Robert B. West et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)
Clinical significance of Myb protein and downstream target genes in salivary adenoid cystic carcinoma
Diana Bell et al.
CANCER BIOLOGY & THERAPY (2011)
Novel Chromosomal Rearrangements and Break Points at the t(6;9) in Salivary Adenoid Cystic Carcinoma: Association with MYB-NFIB Chimeric Fusion, MYB Expression, and Clinical Outcome
Yoshitsugu Mitani et al.
CLINICAL CANCER RESEARCH (2011)
Analysis of MYB expression and MYB-NFIB gene fusions in adenoid cystic carcinoma and other salivary neoplasms
Louis B. Brill et al.
MODERN PATHOLOGY (2011)
Loss of 6q or 8p23 is associated with the total number of DNA copy number aberrations in adenoid cystic carcinoma
Atsunori Oga et al.
ONCOLOGY REPORTS (2011)
Comprehensive Analysis of the MYB-NFIB Gene Fusion in Salivary Adenoid Cystic Carcinoma: Incidence, Variability, and Clinicopathologic Significance
Yoshitsugu Mitani et al.
CLINICAL CANCER RESEARCH (2010)
Expression of c-kit and Slug correlates with invasion and metastasis of salivary adenoid cystic carcinoma
Yaling Tang et al.
ORAL ONCOLOGY (2010)
Cetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II study
L. D. Locati et al.
ORAL ONCOLOGY (2009)
Genetic Profiling Reveals Cross-Contamination and Misidentification of 6 Adenoid Cystic Carcinoma Cell Lines: ACC2, ACC3, ACCM, ACCNS, ACCS and CAC2
Janyaporn Phuchareon et al.
PLOS ONE (2009)
Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck
Marta Persson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Deletion of 1p32-p36 is the most frequent genetic change and poor prognostic marker in adenoid cystic carcinoma of the salivary glands
Pulivarthi H. Rao et al.
CLINICAL CANCER RESEARCH (2008)
High-resolution array comparative genomic hybridization analysis of human bronchial and salivary adenoid cystic carcinoma
Alain Bernheim et al.
LABORATORY INVESTIGATION (2008)
Adenoid cystic carcinoma with high-grade transformation: A report of 11 cases and a review of the literature
Raja R. Seethala et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2007)
Phase II study of lapatinib in recurrent or metastatic epidermal growth factor receptor and/or erbB2 expressing adenoid cystic carcinoma and non-adenoid cystic carcinoma malignant tumors of the salivary glands
Mark Agulnik et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
A phase II study of imatinib for advanced adenoid cystic carcinoma of head and neck salivary glands
M. Raphael Pfeffer et al.
ORAL ONCOLOGY (2007)
Chromosome 6 deletion and candidate tumor suppressor genes in adenoid cystic carcinoma
Sue Rutherford et al.
CANCER LETTERS (2006)
Differential KIT expression in histological subtypes of adenoid cystic carcinoma (ACC) of the salivary gland
K Freier et al.
ORAL ONCOLOGY (2005)
Imatinib mesylate in patients with adenoid cystic cancers of the salivary glands expressing c-kit: A Princess Margaret Hospital phase II consortium study
SJ Hotte et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
C-kit expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and monomorphic adenoma
PC Edwards et al.
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS (2003)
Dedifferentiated adenoid cystic carcinoma: A clinicopa-thologic study of 6 cases
T Nagao et al.
MODERN PATHOLOGY (2003)
C-kit expression distinguishes salivary gland adenoid cystic carcinoma from polymorphous low-grade adenocarcinoma
CR Penner et al.
MODERN PATHOLOGY (2002)
Loss of heterozygosity at chromosome 6q23-25 correlates with clinical and histologic parameters in salivary gland adenoid cystic carcinoma
I Stallmach et al.
VIRCHOWS ARCHIV (2002)
分享论文
